MAPT and Alzheimer disease: Mechanistic studies are needed to clarify whether NEEV-miRNAs contribute to AD pathogenesis or reflect downstream neurodegeneration, including evaluation of miR-122-5p regulatory networks in relation to Aβ and tau pathology.